833 related articles for article (PubMed ID: 24103921)
1. Patterns of growth in ambulatory males with Duchenne muscular dystrophy.
West NA; Yang ML; Weitzenkamp DA; Andrews J; Meaney FJ; Oleszek J; Miller LA; Matthews D; DiGuiseppi C
J Pediatr; 2013 Dec; 163(6):1759-1763.e1. PubMed ID: 24103921
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroid Treatment and Growth Patterns in Ambulatory Males with Duchenne Muscular Dystrophy.
Lamb MM; West NA; Ouyang L; Yang M; Weitzenkamp D; James K; Ciafaloni E; Pandya S; DiGuiseppi C;
J Pediatr; 2016 Jun; 173():207-213.e3. PubMed ID: 27039228
[TBL] [Abstract][Full Text] [Related]
3. Growth and psychomotor development of patients with Duchenne muscular dystrophy.
Sarrazin E; von der Hagen M; Schara U; von Au K; Kaindl AM
Eur J Paediatr Neurol; 2014 Jan; 18(1):38-44. PubMed ID: 24100172
[TBL] [Abstract][Full Text] [Related]
4. The effect of steroid treatment on weight in nonambulatory males with Duchenne muscular dystrophy.
Lamb MM; Cai B; Royer J; Pandya S; Soim A; Valdez R; DiGuiseppi C; James K; Whitehead N; Peay H; Venkatesh SY; Matthews D;
Am J Med Genet A; 2018 Nov; 176(11):2350-2358. PubMed ID: 30256515
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of Pediatric-Onset Duchenne and Becker Muscular Dystrophy Subphenotypes Using Data from the Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet).
Andrews JG; Lamb MM; Conway KM; Street N; Westfield C; Ciafaloni E; Matthews D; Pandya S;
J Neuromuscul Dis; 2022; 9(1):171-178. PubMed ID: 34776418
[TBL] [Abstract][Full Text] [Related]
6. Patients with Duchenne muscular dystrophy are significantly shorter than those with Becker muscular dystrophy, with the higher incidence of short stature in Dp71 mutated subgroup.
Matsumoto M; Awano H; Lee T; Takeshima Y; Matsuo M; Iijima K
Neuromuscul Disord; 2017 Nov; 27(11):1023-1028. PubMed ID: 28734761
[TBL] [Abstract][Full Text] [Related]
7. Electromyographic pattern in Duchenne and Becker muscular dystrophy. Part II. Electromyographic pattern in Becker muscular dystrophy in comparison with Duchenne muscular dystrophy.
Emeryk-Szajewska B; Kopeć J
Electromyogr Clin Neurophysiol; 2008; 48(6-7):279-84. PubMed ID: 18837193
[TBL] [Abstract][Full Text] [Related]
8. Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy.
Barber BJ; Andrews JG; Lu Z; West NA; Meaney FJ; Price ET; Gray A; Sheehan DW; Pandya S; Yang M; Cunniff C
J Pediatr; 2013 Oct; 163(4):1080-4.e1. PubMed ID: 23866715
[TBL] [Abstract][Full Text] [Related]
9. Anesthesia and Duchenne or Becker muscular dystrophy: review of 117 anesthetic exposures.
Segura LG; Lorenz JD; Weingarten TN; Scavonetto F; Bojanić K; Selcen D; Sprung J
Paediatr Anaesth; 2013 Sep; 23(9):855-64. PubMed ID: 23919455
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Duchenne and Becker muscular dystrophies in the United States.
Romitti PA; Zhu Y; Puzhankara S; James KA; Nabukera SK; Zamba GK; Ciafaloni E; Cunniff C; Druschel CM; Mathews KD; Matthews DJ; Meaney FJ; Andrews JG; Conway KM; Fox DJ; Street N; Adams MM; Bolen J;
Pediatrics; 2015 Mar; 135(3):513-21. PubMed ID: 25687144
[TBL] [Abstract][Full Text] [Related]
11. Body composition and resting energy expenditure of individuals with Duchenne and Becker muscular dystrophy.
Hogan SE
Can J Diet Pract Res; 2008; 69(4):208-12. PubMed ID: 19063812
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years - four states, 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(40):1119-22. PubMed ID: 19834452
[TBL] [Abstract][Full Text] [Related]
13. Urological manifestations of Duchenne muscular dystrophy.
Askeland EJ; Arlen AM; Erickson BA; Mathews KD; Cooper CS
J Urol; 2013 Oct; 190(4 Suppl):1523-8. PubMed ID: 23357214
[TBL] [Abstract][Full Text] [Related]
14. Time to diagnosis of Duchenne muscular dystrophy remains unchanged: Findings from the Muscular Dystrophy Surveillance, Tracking, and Research Network, 2000-2015.
Thomas S; Conway KM; Fapo O; Street N; Mathews KD; Mann JR; Romitti PA; Soim A; Westfield C; Fox DJ; Ciafaloni E;
Muscle Nerve; 2022 Aug; 66(2):193-197. PubMed ID: 35312090
[TBL] [Abstract][Full Text] [Related]
15. Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet).
Ciafaloni E; Fox DJ; Pandya S; Westfield CP; Puzhankara S; Romitti PA; Mathews KD; Miller TM; Matthews DJ; Miller LA; Cunniff C; Druschel CM; Moxley RT
J Pediatr; 2009 Sep; 155(3):380-5. PubMed ID: 19394035
[TBL] [Abstract][Full Text] [Related]
16. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy.
McDonald CM; Henricson EK; Han JJ; Abresch RT; Nicorici A; Elfring GL; Atkinson L; Reha A; Hirawat S; Miller LL
Muscle Nerve; 2010 Apr; 41(4):500-10. PubMed ID: 19941337
[TBL] [Abstract][Full Text] [Related]
17. Ambulatory capacity and disease progression as measured by the 6-minute-walk-distance in Duchenne muscular dystrophy subjects on daily corticosteroids.
Goemans N; van den Hauwe M; Wilson R; van Impe A; Klingels K; Buyse G
Neuromuscul Disord; 2013 Aug; 23(8):618-23. PubMed ID: 23770101
[TBL] [Abstract][Full Text] [Related]
18. Evolution of gastric electrical features and gastric emptying in children with Duchenne and Becker muscular dystrophy.
Borrelli O; Salvia G; Mancini V; Santoro L; Tagliente F; Romeo EF; Cucchiara S
Am J Gastroenterol; 2005 Mar; 100(3):695-702. PubMed ID: 15743370
[TBL] [Abstract][Full Text] [Related]
19. Bone health in boys with Duchenne Muscular Dystrophy on long-term daily deflazacort therapy.
Mayo AL; Craven BC; McAdam LC; Biggar WD
Neuromuscul Disord; 2012 Dec; 22(12):1040-5. PubMed ID: 22824639
[TBL] [Abstract][Full Text] [Related]
20. Valley sign in Becker muscular dystrophy and outliers of Duchenne and Becker muscular dystrophy.
Pradhan S
Neurol India; 2004 Jun; 52(2):203-5. PubMed ID: 15269471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
